β-cell transplantation in diabetes mellitus

S. Pellegrini, V. Sordi, L. Piemonti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Patients with diabetes mellitus suffer either from destruction of pancreatic β-cells or progressive deterioration of their function. Thus, transplantation of an intact β-cell population fully capable of insulin secretion is the only means to cure this disease. Despite glycemic benefits and decrease in risks for late complications, islet transplantation or complete pancreatic grafting in humans remains a challenge due to necessity of lifetime immunosuppression and increasingly sparse donor resources. Current paper presents a review of modern endeavours to obtain a limitless source for glucose-sensitive insulin secreting cells. We discuss, in particular, complex aspects of β-cell proliferation and/or neogenesis in vivo, issues with xenogenous pancreatic islets, and latest advances in controlled differentiation of embryonic and induced polypotent stem cells - the most promising and relevant source of β-cells.

Original languageEnglish
Pages (from-to)11-20
Number of pages10
JournalDiabetes Mellitus
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Cell Transplantation
Diabetes Mellitus
Islets of Langerhans Transplantation
Insulin-Secreting Cells
Islets of Langerhans
Immunosuppression
Stem Cells
Cell Proliferation
Tissue Donors
Insulin
Glucose
Population

Keywords

  • Diabetes mellirus
  • Pancreatic β-cells
  • Proliferation
  • Stem cells

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Endocrinology

Cite this

β-cell transplantation in diabetes mellitus. / Pellegrini, S.; Sordi, V.; Piemonti, L.

In: Diabetes Mellitus, No. 3, 2013, p. 11-20.

Research output: Contribution to journalArticle

Pellegrini, S. ; Sordi, V. ; Piemonti, L. / β-cell transplantation in diabetes mellitus. In: Diabetes Mellitus. 2013 ; No. 3. pp. 11-20.
@article{422a752085664b0a8e6e9ba573ab53b6,
title = "β-cell transplantation in diabetes mellitus",
abstract = "Patients with diabetes mellitus suffer either from destruction of pancreatic β-cells or progressive deterioration of their function. Thus, transplantation of an intact β-cell population fully capable of insulin secretion is the only means to cure this disease. Despite glycemic benefits and decrease in risks for late complications, islet transplantation or complete pancreatic grafting in humans remains a challenge due to necessity of lifetime immunosuppression and increasingly sparse donor resources. Current paper presents a review of modern endeavours to obtain a limitless source for glucose-sensitive insulin secreting cells. We discuss, in particular, complex aspects of β-cell proliferation and/or neogenesis in vivo, issues with xenogenous pancreatic islets, and latest advances in controlled differentiation of embryonic and induced polypotent stem cells - the most promising and relevant source of β-cells.",
keywords = "Diabetes mellirus, Pancreatic β-cells, Proliferation, Stem cells",
author = "S. Pellegrini and V. Sordi and L. Piemonti",
year = "2013",
doi = "10.14341/2072-0351-812",
language = "English",
pages = "11--20",
journal = "Diabetes Mellitus",
issn = "2072-0351",
publisher = "UP Print LLC",
number = "3",

}

TY - JOUR

T1 - β-cell transplantation in diabetes mellitus

AU - Pellegrini, S.

AU - Sordi, V.

AU - Piemonti, L.

PY - 2013

Y1 - 2013

N2 - Patients with diabetes mellitus suffer either from destruction of pancreatic β-cells or progressive deterioration of their function. Thus, transplantation of an intact β-cell population fully capable of insulin secretion is the only means to cure this disease. Despite glycemic benefits and decrease in risks for late complications, islet transplantation or complete pancreatic grafting in humans remains a challenge due to necessity of lifetime immunosuppression and increasingly sparse donor resources. Current paper presents a review of modern endeavours to obtain a limitless source for glucose-sensitive insulin secreting cells. We discuss, in particular, complex aspects of β-cell proliferation and/or neogenesis in vivo, issues with xenogenous pancreatic islets, and latest advances in controlled differentiation of embryonic and induced polypotent stem cells - the most promising and relevant source of β-cells.

AB - Patients with diabetes mellitus suffer either from destruction of pancreatic β-cells or progressive deterioration of their function. Thus, transplantation of an intact β-cell population fully capable of insulin secretion is the only means to cure this disease. Despite glycemic benefits and decrease in risks for late complications, islet transplantation or complete pancreatic grafting in humans remains a challenge due to necessity of lifetime immunosuppression and increasingly sparse donor resources. Current paper presents a review of modern endeavours to obtain a limitless source for glucose-sensitive insulin secreting cells. We discuss, in particular, complex aspects of β-cell proliferation and/or neogenesis in vivo, issues with xenogenous pancreatic islets, and latest advances in controlled differentiation of embryonic and induced polypotent stem cells - the most promising and relevant source of β-cells.

KW - Diabetes mellirus

KW - Pancreatic β-cells

KW - Proliferation

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84888097681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888097681&partnerID=8YFLogxK

U2 - 10.14341/2072-0351-812

DO - 10.14341/2072-0351-812

M3 - Article

SP - 11

EP - 20

JO - Diabetes Mellitus

JF - Diabetes Mellitus

SN - 2072-0351

IS - 3

ER -